RET Oncoprotein

Human RET Oncoprotein is a product of mutated variants (Oncogene RET) of RET Gene, which encodes Tyrosine-Protein Kinase Receptor RET, a type I membrane protein receptor for Glial Cell Line-Derived with an extracellular cadherin-like domain and important in neural crest development. Some oncogenic RET point mutations cause constitutive kinase activation. PTC1 oncogene involves fusion of RET kinase to the H4 dimerization leucine zipper. In PTC6, RET is fused to the N-terminal part of Transcriptional Intermediary Factor-1-Alpha. In PTC7, RET is fused to a C-terminal part of TIF1-Gamma. Oncogenic RET mutations are associated with Hirschsprung's disease, Multiple Endocrine Neoplasia, pheochromocytoma, hyperparathyroidism and medullary thyroid cancer. RET Oncoprotein disrupts normal cell function. (NCI Thesaurus)

YOU MAY ALSO LIKE

RET Gene Product

A protein encoded by the RET gene.

RET Gene

This gene plays an essential role in neural crest development, cellular growth and differentiation. Mutations in the gene are associated with a…

RET Finger Protein 2

Encoded by human RFP2 Gene (TRIM Family), 407-aa 47-kDa RET Finger Protein 2, of unknown function, is localized to cytoplasmic bodies near…

Resveratrol Formulation SRT501

A proprietary formulation of resveratrol, a polyphenolic phytoalexin derived from grapes and other food products with potential antioxidant, anti-obesity, antidiabetic and chemopreventive…

Resveratrol

A substance found in the skins of grapes and in certain other plants, fruits, and seeds. It is made by various plants…

Resuscitation

The measures applied for the restoration a person to life and/or consciousness. The act of resuscitation includes such components as artificial respiration…